X @Forbes

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. (Photo: Maria Ponce) https://t.co/L8rVPGVJho https://t.co/YEu4NUXCGS ...